Intended for licensed healthcare professionals located in the United Kingdom and Republic of Ireland only
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse events.
Our websites that use cookies will have a cookie banner prominently displayed with an option to access the Cookie Settings. This allows you to learn more about the cookies used by that website and to decide whether to accept or reject them based on their intended purpose(s) and duration(s).
You may withdraw your consent to the use of any cookies (except for strictly necessary cookies) directly at any time by going to the Cookie Settings for respective Incyte website. Withdrawing your consent does not affect the legality of processing carried out previously. Your refusal or the withdrawal of your consent does not prevent you from using the websites.
You may prevent the use of all cookies (except for strictly necessary cookies) and delete them by changing your browser settings.
If you deactivate cookies, your user experience may be of lower quality. In particular, we cannot keep your preferences for audience measurement cookies for your subsequent visits to our websites. As a result, the next time you visit the website, the cookie banner will again appear.
You can further manage your privacy by reviewing your website browser's Cookie Settings.
For more information on our approach to privacy, how we handle your personal information and how you can exercise your data protection rights, please see our Privacy Policy.
Your personal information may be transferred outside your country of residence into countries that do not guarantee the same level of data protection. In these cases, and where required, we use appropriate data transfer mechanisms as required by applicable personal information laws and regulations. For example, if you are a resident of the European Economic Area or United Kingdom, we will have standard contractual clauses and additional necessary measures in place to ensure the legality of such transfers.
In connection with the use of Google’s services, your data described above may be hosted on Google’s servers located in the United States.
Depending on your location, you may consult these mechanisms and guarantees by contacting us at the address provided below.
If you have any questions, need more information or wish to exercise your rights regarding your personal information, please contact Incyte’s Privacy Office at the address below:
Incyte
Attention: Privacy Office
Incyte Corporation
1801 Augustine Cut-off
Wilmington, Delaware 19803
United States of America
privacy@incyte.com
For EEA, UK and Swiss Residents please contact:
Incyte Biosciences International Sàrl
Attention: Data Protection Officer
Rue Docteur-Yersin 12, 1110, Morges,
Switzerland
privacy@incyte.com
Our Cookie Policy was last updated on January 18, 2024.
Click here to be kept up to date with the latest news in oncology
UNITED KINGDOM
Adverse events should be reported. Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Incyte by calling 00‑800‑0002‑7423.
REPUBLIC OF IRELAND
Adverse events should be reported.Reporting forms and information can be found at HPRA Pharmacovigilance: www.hpra.ie. Adverse events should also be reported to Incyte immediately by phoning the Toll-free phone number 1800‑456‑748.
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.
This medicinal product has been authorised under a 'conditional approval' scheme. This means that further evidence on this medicinal product is awaited.
IE/PEMA/P/25/0010
Date of preparation: January 2025
Developed and funded by Incyte Biosciences International Sàrl.
© 2025, Incyte. All rights reserved.
PEMAZYRE, the PEMAZYRE logo and the Incyte logo are registered trademarks of Incyte.
Intended for licensed healthcare professionals located in the United Kingdom and Republic of Ireland only.
You are now leaving the Incyte PEMAZYRE website. This link will take you to a site that is not owned or maintained by Incyte. Incyte is not responsible for the information contained on third–party sites. Would you like to continue?
Intended for licensed healthcare professionals located in the United Kingdom and Republic of Ireland only.
You are now leaving the Incyte PEMAZYRE website. This link will take you to the site https://www.incyte.com, owned by Incyte Corporation and managed by the company. Would you like to continue?